arrow
M

Meng Xu-Welliver

Mayo Clinic
H指数:28
被引数:2,253

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PARP inhibitors potentiate proton therapy end-of-range effects by accelerating replication forks and promoting transcription conflict

PARP抑制剂通过加速复制叉和促进转录冲突,增强了质子治疗射程末端的效应。

2025-08-270
OAAI
Hypofractionated Preoperative Radiation Therapy for Extremity and Superficial Trunk Soft Tissue Sarcomas: Results of a Prospective, Phase 2 Trial

肢体及浅表躯干软组织肉瘤的术前低分割放射治疗:一项前瞻性、Ⅱ期试验的结果

2025-05-170
PRE
Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients

循环肿瘤DNA预测手术非小细胞肺癌患者新辅助免疫治疗疗效和无复发生存期

2022-02-0155
OAAI
Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer

治疗前血清碳酸氢盐预测局部非小细胞肺癌患者立体定向放射治疗后的原发肿瘤控制

2019-11-011
OAAI
Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database

确定非手术治疗的III期非小细胞肺癌老年患者的护理模式: 国家癌症数据库的分析

2018-10-0520
OAAI